References
Ando, T.; Yamasaki, M.; Suzuki, K. Protamines: isolation, characterization, structure and function. In: Kleinzeller, A.; Springer, P. G. F.; Wittmann, H. G. Molecular biology biochemistry and biophysics. Vol. 12. New York:Springer-Verlag; 1973.
Blau, H. M.; Webster, C.; Pavlath, G. K. Defective myoblasts identified in Duchenne muscular dystrophy. Proc. Natl. Acad. Sci. USA 80:4856–4860; 1983.
Cohen, S. Epidermal growth factor. In Vitro Cell. Dev. Bio. 23:239–246; 1987.
Dauchel, M. C.; Courty, J.; Mereau, A., et al. Modulation of mitogenic activity and cellular binding of basic fibroblast growth factor by basic proteins. J. Cell. Biochem. 39:411–420; 1989.
Felix, K. Protamines. In: Anfinsen, C. B., Jr.; Anson, M. L.; Bailey, K., et al. eds. Advances in protein chemistry, Vol. 15. New York: Academic Press; 1960:1–56.
Ham, R. G.; St. Clair, J. A.; Webster, C., et al. Improved media for normal human muscle satellite cells: serum-free clonal growth and enhanced growth with low serum. In Vitro Cell. Dev. Bio. 24:833–844; 1988.
Huang, R.-C. C.; Bonner, J.; Murray, K. Physical and biological properties of soluble nucleohistones. J. Mol. Biol. 8:54–64; 1964.
Huang, J. S.; Nishimura, J.; Huang, S. S., et al.Protamine inhibits platelet derived growth factor receptor activity but not epidermal growth factor activity. J. Cell. Biochem. 26:205–220; 1984.
Loeshwar, V. B.; Huang, S. S.; Huang, J. S. Protamine enhances epidermal growth factor (EGF)-stimulated mitogenesis by increasing cell surface EGF receptor number: implications for existence of cryptic EGF receptors. J. Biol. Chem. 264:19318–19326; 1989.
McKeehan, W. L.; Ham, R. G. Stimulation of clonal growth of normal fibroblasts with substrata coated with basic polymers. J. Cell Bio. 71:727–734; 1976.
Majewski, S.; Kaminski, M. J.; Szmurlo, A., et al. Inhibition of tumor induced angiogenesis by systematically administered protamine sulfate. Int. J. Cancer 33:831–833; 1984.
Meyer, S. D.; St.Clair, J. A.; Ham, R. G. EGF is a mitogen for human skeletal muscle satellite cells (HMSC) but does not block their differentiation. J. Cell Bio. 109:305a; 1989.
Miescher, F. Das Protamine, eine neue organische Base aus den Samenfaden des Rheinlachses. Ber. 7:376–379; 1874.
Neufeld, G.; Gospodarowicz, D. Protamine sulfate inhibits mitogenic activities of the extracellular matrix and fibroblast growth factor, but potentiates that of epidermal growth factor. J. Cell. Physiol. 132:287–294; 1987.
Pedersen, K. O. Fetuin, a new globulin isolated from serum. Nature, Lond. 154:575; 1944.
Smith, J. R.; Hayflick, L. Variation in the life-span of clones derived from human diploid cell strains. J. Cell Bio. 62:48–53; 1974.
Smith, J. R.; Pereira-Smith, O. M.; Schneider, E. L. Colony size distributions as a measure of in vivo and in vitro aging. Proc. Natl. Acad. Sci. USA 75:1353–1356; 1978
Taylor, S.; Folkman, J. Protamine is an inhibitor of angiogenesis. Nature 297:307–312; 1982.
Author information
Authors and Affiliations
Additional information
The tissue specimens were obtained from the Cooperative Human Tissue Network which is funded by the National Cancer Institute. This work was supported by an NIH grant (AR 39860).
Rights and permissions
About this article
Cite this article
Nie, Z., Ham, R.G. Protamine stimulates serum-free growth of human muscle cells. In Vitro Cell Dev Biol – Animal 27, 677–680 (1991). https://doi.org/10.1007/BF02633209
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02633209